Skip to content

Kardigan (KARD) IPO deck

Kardigan is a clinical-stage biotechnology company focused on developing precision therapies for cardiovascular diseases with significant unmet medical needs.

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest